NEUROPACE, INC. Basic Shares Outstanding (Weighted Average)
NEUROPACE, INC. (NPCE) reported Basic Shares Outstanding (Weighted Average) of 34.10 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- NEUROPACE, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 34.10M shares, a 3.78% increase year-over-year.
- NEUROPACE, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 33.72M shares, a 7.10% increase year-over-year.
- NEUROPACE, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 33.39M shares, a 11.62% increase year-over-year.
- NEUROPACE, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 33.13M shares, a 12.53% increase year-over-year.
- NEUROPACE, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 32.72M shares, a 12.35% increase from fiscal 2024.
- NEUROPACE, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 29.13M shares, a 12.67% increase from fiscal 2023.
- NEUROPACE, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 25.85M shares, a 5.11% increase from fiscal 2022.
- NEUROPACE, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 24.59M shares, a 48.08% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 34.10M shares 10-Q · filed 2026-08-11 | 33.91M shares 10-Q · filed 2026-08-11 | 33.74M shares derived: average of 3 quarters · filed 2026-08-11 | 33.59M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 33.72M shares 10-Q · filed 2026-05-12 | 33.55M shares derived: average of 2 quarters · filed 2026-05-12 | 33.41M shares derived: average of 3 quarters · filed 2026-05-12 | 33.28M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 33.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 33.26M shares derived: average of 2 quarters · filed 2026-03-03 | 33.13M shares derived: average of 3 quarters · filed 2026-08-11 | 32.72M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 33.13M shares 10-Q · filed 2025-11-04 | 33.00M shares derived: average of 2 quarters · filed 2026-08-11 | 32.50M shares 10-Q · filed 2025-11-04 | 31.85M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 32.86M shares 10-Q · filed 2026-08-11 | 32.18M shares 10-Q · filed 2026-08-11 | 31.42M shares derived: average of 3 quarters · filed 2026-08-11 | 30.93M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 31.48M shares 10-Q · filed 2026-05-12 | 30.70M shares derived: average of 2 quarters · filed 2026-05-12 | 30.28M shares derived: average of 3 quarters · filed 2026-05-12 | 29.92M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 29.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 29.68M shares derived: average of 2 quarters · filed 2026-03-03 | 29.40M shares derived: average of 3 quarters · filed 2026-03-03 | 29.13M shares 10-K · filed 2026-03-03 |
| 2024-09-30 | 29.44M shares 10-Q · filed 2025-11-04 | 29.15M shares derived: average of 2 quarters · filed 2025-11-04 | 28.86M shares 10-Q · filed 2025-11-04 | 28.35M shares derived: average of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | 28.85M shares 10-Q · filed 2025-08-12 | 28.57M shares 10-Q · filed 2025-08-12 | 27.98M shares derived: average of 3 quarters · filed 2025-08-12 | 27.49M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 28.29M shares 10-Q · filed 2025-05-13 | 27.55M shares derived: average of 2 quarters · filed 2025-05-13 | 27.04M shares derived: average of 3 quarters · filed 2025-05-13 | 26.65M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 26.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 26.41M shares derived: average of 2 quarters · filed 2025-03-04 | 26.10M shares derived: average of 3 quarters · filed 2025-03-04 | 25.85M shares 10-K · filed 2025-03-04 |
| 2023-09-30 | 26.02M shares 10-Q · filed 2024-11-12 | 25.74M shares derived: average of 2 quarters · filed 2024-11-12 | 25.53M shares 10-Q · filed 2024-11-12 | 25.36M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 25.47M shares 10-Q · filed 2024-08-13 | 25.29M shares 10-Q · filed 2024-08-13 | 25.13M shares derived: average of 3 quarters · filed 2024-08-13 | 25.03M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 25.10M shares 10-Q · filed 2024-05-08 | 24.97M shares derived: average of 2 quarters · filed 2024-05-08 | 24.89M shares derived: average of 3 quarters · filed 2024-05-08 | 24.79M shares derived: average of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | 24.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 24.78M shares derived: average of 2 quarters · filed 2024-03-05 | 24.69M shares derived: average of 3 quarters · filed 2024-03-05 | 24.59M shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 24.73M shares 10-Q · filed 2023-11-06 | 24.62M shares derived: average of 2 quarters · filed 2023-11-06 | 24.51M shares 10-Q · filed 2023-11-06 | 24.45M shares derived: average of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | 24.50M shares 10-Q · filed 2023-08-08 | 24.41M shares 10-Q · filed 2023-08-08 | 24.35M shares derived: average of 3 quarters · filed 2023-08-08 | 24.29M shares derived: average of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 24.31M shares 10-Q · filed 2023-05-04 | 24.28M shares derived: average of 2 quarters · filed 2023-05-04 | 24.22M shares derived: average of 3 quarters · filed 2023-05-04 | 22.55M shares derived: average of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | 24.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 24.18M shares derived: average of 2 quarters · filed 2023-03-02 | 21.97M shares derived: average of 3 quarters · filed 2023-03-02 | 16.61M shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 24.10M shares 10-Q · filed 2022-11-08 | 20.83M shares derived: average of 2 quarters · filed 2022-11-08 | 14.06M shares 10-Q · filed 2022-11-08 | 10.53M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 17.55M shares 10-Q · filed 2022-08-11 | 8.96M shares 10-Q · filed 2022-08-11 | 6.01M shares derived: average of 3 quarters · filed 2022-08-11 | 4.56M shares derived: average of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 269.18K shares 10-Q · filed 2022-05-12 | 239.15K shares derived: average of 2 quarters · filed 2022-05-12 | 226.90K shares derived: average of 3 quarters · filed 2022-05-12 | 220.78K shares derived: average of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | 209.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 205.77K shares derived: average of 2 quarters · filed 2022-03-10 | 204.64K shares derived: average of 3 quarters · filed 2022-03-10 | 204.07K shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 202.41K shares 10-Q · filed 2021-11-10 | 202.40K shares derived: average of 2 quarters · filed 2021-11-10 | 202.38K shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 202.40K shares 10-Q · filed 2021-08-12 | 202.37K shares 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 202.34K shares 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |